| Name | Orbifloxacin |
|---|---|
| Synonyms |
1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
Orbifloxacin 3-Quinolinecarboxylic acid, 1-cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo- 1-cyclopropyl-7-[(3S,5R)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic acid Orbax 1-Cyclopropyl-7-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid MFCD00864858 |
| Description | Orbifloxacin is a synthetic broad-spectrum fluoroquinolone antibiotic which is approved for use in dogs. |
|---|---|
| Related Catalog |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 590.7±50.0 °C at 760 mmHg |
| Melting Point | 260 °C(dec.) |
| Molecular Formula | C19H20F3N3O3 |
| Molecular Weight | 395.376 |
| Flash Point | 311.1±30.1 °C |
| Exact Mass | 395.145691 |
| PSA | 74.57000 |
| LogP | 2.37 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.588 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
~72%
113617-63-3 |
| Literature: Miyamoto, Teruyuki; Matsumoto, Jun-ichi; Chiba, Katsumi; Egawa, Hiroshi; Shibamori, Koh-ichiro; et al. Journal of Medicinal Chemistry, 1990 , vol. 33, # 6 p. 1645 - 1656 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |